Transcranial Sonography Findings in Alzheimer's Disease: A New Imaging Biomarker.

CONCLUSION: Our results suggest that TCS may be an alternative imaging tool for the assessment of MTL atrophy and ventricular enlargement for patients in whom MRI scanning is not possible. Additionally, TCS offers a practical, patient-friendly and inexpensive option for the screening and follow-up of individuals with AD. PMID: 32492728 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32492728?dopt=Abstract

Source: Ultraschall in der Medizin - June 2, 2020 Category: Radiology Authors: Yilmaz R, Granert O, Schäffer E, Jensen-Kondering U, Schulze S, Bartsch T, Berg D Tags: Ultraschall Med Source Type: research

More News: Alzheimer's | PET Scan | Radiology